February 28, 2025

ODYSSEY Study: Dolutegravir Reduces Virologic Failure in Children

Dolutegravir led to faster virologic suppression and lower virologic failure rates than standard care, according to the ODYSSEY trial's latest analysis.

Conexiant

February 28, 2025

mRNA Vaccination Linked to Fewer Post-COVID Symptoms in Children

Researchers found an association between mRNA vaccination and lower odds of PCC in children.

Conexiant

February 27, 2025

Ultrasound Markers for Placenta Accreta Spectrum Risk

"Our findings emphasize the critical importance of early, timely, and consistent monitoring of the placenta using medical imaging."

Conexiant

February 26, 2025

New Medical Malpractice Rules Issued by American Law Institute

The American Law Institute's first restatement of medical malpractice law shifts focus from customary practice to evidence-based medicine.

Conexiant

February 25, 2025

Youth Diabetes Study: Closed-Loop Therapy's Dual Impact

Hybrid closed-loop insulin therapy reduces hypoglycemic coma risk and improves glycemic control but raises diabetic ketoacidosis risk in young patients with type 1 diabetes, a large population-based study finds.

Conexiant

February 21, 2025

CDC: Measles Cases Surge Amid Texas Outbreak

Measles cases in the U.S. surged from 14 to 93 in one week, with 95% of infections in unvaccinated or immunity-unknown individuals, per the CDC.

Reuters

February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant